Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects

• Status: Completed
• Trial end date: 2009-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and efficacy of intravenous 6β-Naltrexol administered to opiate dependent subjects

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: California Pacific Medical Center Research Institute
• Treatments: Analgesics, Opioid; Lactulose; Naloxone

Criteria

Inclusion Criteria:

• Opiate dependent males and females age 21-45 on stable doses of methadone

• Fluent English speaker

• Willing and able to give written consent

Exclusion Criteria:

• Pregnancy or lactation

FOR MORE DETAILS CONTACT THE RESEARCH CLINIC.